These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28404358)

  • 1. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Jiang HY; Wang SY; Deng M; Li YC; Ling ZX; Shao L; Ruan B
    Vaccine; 2017 May; 35(20):2633-2641. PubMed ID: 28404358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
    Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES.
    Cunha IS; Silva TCD; Malluta ÉF; Scolaro BL; Velho PS; Stall J
    Arq Gastroenterol; 2020; 57(1):69-73. PubMed ID: 32294738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience.
    Leung WK; Liu KSh; Seto WK; Chan KH; Tong T; Yuen MF; Lai CL; Hung IF
    J Dig Dis; 2013 Nov; 14(11):596-603. PubMed ID: 23870196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: hepatitis B vaccination in inflammatory bowel disease.
    Singh AK; Jena A; Mahajan G; Mohindra R; Suri V; Sharma V
    Aliment Pharmacol Ther; 2022 Apr; 55(8):908-920. PubMed ID: 35261057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.
    Gisbert JP; Menchén L; García-Sánchez V; Marín I; Villagrasa JR; Chaparro M
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1379-85. PubMed ID: 22530631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
    Loras C; Gisbert JP; Saro MC; Piqueras M; Sánchez-Montes C; Barrio J; Ordás I; Montserrat A; Ferreiro R; Zabana Y; Chaparro M; Fernández-Bañares F; Esteve M;
    J Crohns Colitis; 2014 Nov; 8(11):1529-38. PubMed ID: 25052345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease.
    Sempere L; Almenta I; Barrenengoa J; Gutiérrez A; Villanueva CO; de-Madaria E; García V; Sánchez-Payá J
    Vaccine; 2013 Jun; 31(30):3065-71. PubMed ID: 23664999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Pratt PK; David N; Weber HC; Little FF; Kourkoumpetis T; Patts GJ; Weinberg J; Farraye FA
    Inflamm Bowel Dis; 2018 Jan; 24(2):380-386. PubMed ID: 29361083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
    Ni JD; Xiong YZ; Wang XJ; Xiu LC
    Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Li X; Xu Y; Dong Y; Yang X; Ye B; Wang Y; Chen Y
    Vaccine; 2018 Apr; 36(18):2442-2449. PubMed ID: 29588118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.
    Kim ES; Cho KB; Park KS; Jang BI; Kim KO; Jeon SW; Kim EY; Yang CH; Kim WJ;
    J Clin Gastroenterol; 2014 Jul; 48(6):553-8. PubMed ID: 24162170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.
    Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
    Am J Gastroenterol; 2012 Oct; 107(10):1460-6. PubMed ID: 23034605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination.
    Cossio-Gil Y; Martínez-Gómez X; Campins-Martí M; Rodrigo-Pendás JÁ; Borruel-Sainz N; Rodríguez-Frías F; Casellas-Jordà F
    J Gastroenterol Hepatol; 2015 Jan; 30(1):92-8. PubMed ID: 25160690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.
    Altunöz ME; Senateş E; Yeşil A; Calhan T; Ovünç AO
    Dig Dis Sci; 2012 Apr; 57(4):1039-44. PubMed ID: 22147248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.